THERIVA BIOLOGICS INC (TOVX) Stock Balance Sheet
NYSEARCA:TOVX - American Stock Exchange - US87164U5083 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 16.41M | 23.18M | 41.79M | 67.33M | 6.23M | |||
| Receivables | 2.00M | 1.94M | 230.00K | 0.00 | 470.00K | |||
| Other Current Assets | 1.12M | 2.29M | 3.50M | 1.53M | 1.24M | |||
| Total Current Assets | 19.53M | 27.40M | 45.52M | 68.86M | 7.93M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.39M | 21.94M | 20.69M | 1.48M | 450.00K | |||
| Goodwill | 0.00 | 5.70M | 5.53M | N/A | N/A | |||
| Other Non-Current Assets | 182.00K | 180.00K | 120.00K | 20.00K | 20.00K | |||
| Total Non-Current Assets | 20.57M | 27.82M | 26.34M | 1.51M | 480.00K | |||
| TOTAL ASSETS | 40.11M | 55.22M | 71.86M | 70.37M | 8.41M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 65.00K | 63.00K | 60.00K | N/A | N/A | |||
| Accrued Expenses | 5.59M | 5.00M | 3.12M | 3.03M | 2.08M | |||
| Accounts Payable | 756.00K | 770.00K | 920.00K | 520.00K | 890.00K | |||
| Other Current Liabilities | 916.00K | 906.00K | 2.97M | N/A | N/A | |||
| Total Current Liabilities | 7.32M | 6.74M | 7.06M | 3.55M | 2.97M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 98.00K | 162.00K | 220.00K | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | 0.00 | 1.62M | N/A | N/A | |||
| Other Non-Current Liabilities | 8.05M | 8.62M | 8.40M | 1.40M | 190.00K | |||
| Total Non-Current Liabilities | 8.15M | 8.78M | 10.24M | 1.41M | -2.59M | |||
| TOTAL LIABILITIES | 15.47M | 15.52M | 17.30M | 4.96M | 380.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -330.52M | -309.32M | -290.97M | -271.28M | -248.09M | |||
| Additional Paid In Capital | 355.33M | 346.52M | 343.75M | 336.56M | 240.82M | |||
| Minority Interest | N/A | N/A | N/A | 0.00 | -2.77M | |||
| Common Shares | 3.00K | 2.75M | 2.75M | 130.00K | 15.31M | |||
| Treasury Stock | -288.00K | -288.00K | -290.00K | N/A | N/A | |||
| Other Shareholders' Equity | 112.00K | 32.00K | -680.00K | N/A | N/A | |||
| Shares Outstanding | 2.62M | 17.15M | 15.12M | 13.20M | 2.92M | |||
| Tangible Book Value per Share | 9.41 | 1.82 | 3.06 | 4.96 | -2.48 | |||
| Total Shareholders' Equity | 24.64M | 39.70M | 54.56M | 65.41M | 8.03M | |||
| TOTAL LIABILITIES AND EQUITY | 40.11M | 55.22M | 71.86M | 70.37M | 8.41M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Current Ratio | 2.67 | 4.07 | 6.45 | 19.40 | 2.67 | |||
| Return On Assets (ROA) | -66.55% | -33.23% | -27.87% | -32.95% | -149.35% | |||
| Return On Equity (ROE) | -108.35% | -46.22% | -36.71% | -35.45% | -156.41% | |||
All data in USD , ROIC based on taxRate of 0.21